METTL3 and metabolic dysfunction-associated steatotic liver disease: To independently verify the oncogenic function of METTL3 in NAFLD-HCC, we subjected Mettl3LKI mice and wild-type littermates to DEN plus high-fat, high-cholesterol diet (HFHCD) (Figure 2H).